69
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Topiramate-induced maculopathy in IgG4-related disease

&
Pages 59-63 | Published online: 08 Jun 2016

Reference

  • Lyseng-WilliamsonKAYangLPTopiramate: a review of its use in the treatment of epilepsyDrugs200767152231225617927286
  • Jabbarpoor BonyadiMHSoheilianRSoheilianMTopiramate induced bilateral anterior uveitis associated with hypopyon formationOcul Immunol Inflamm2011191868821034312
  • MaryanoffBENorteySOGardockiJFShankRPDodgsonSPAnti-convulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methyleethylidene)-beta-D-fructopyranose sulfamate and related compoundsJ Med Chem19873058808873572976
  • GuptaPPThackerAKHaiderJDhawanSPandeyNPandeyAKAssessment of topiramate’s efficacy and safety in epilepsyJ Neurosci Rural Pract20145214414824966552
  • ShankRPMaryanoffBEMolecular pharmacodynamics, clinical therapeutics and pharmacokinetics of topiramateCNS Neurosci Ther200814212014218482025
  • Asensio-SánchezVMTorreblanca-AgüeraBMartínez-CalvoSCalvoMJRodríguezRToxicidad oftalmológica severa por Topamax. [Severe ocular side effects with Topamax]Arch Soc Esp Oftalmol2006816345348 Spanish16804780
  • TsuiICasperDChouCLTsangSHElectronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathyDoc Ophthalmol20081161576017912565
  • KjellströmSBruunAIsakssonBErikssonTAndréassonSPonjavicVRetinal function and histopathology in rabbits treated with TopiramateDoc Ophthalmol2006113317918617111186
  • WhiteHSMolecular pharmacology of topiramate: managing seizures and preventing migraineHeadache200545Suppl 1S48S5615833090
  • GualtieriWJanulaJTopiramate maculopathyInt Ophthalmol201333110310623015022
  • SevernPSSymesRRajendramRPalBTopiramate maculopathy secondary to dose titration: first reported caseEye201529798298425931169
  • KoznerPSimonovaKBrozekBSinghKLate acute myopia syndrome induced by a combination of sulphonamide drugsJ Glaucoma2014232e119e12123661047
  • CheukWChanJKIgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entityAdv Anat Pathol201017530333220733352
  • ZenYFujiiTHaradaKTh2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitisHepatology20074561538154617518371
  • FragoulisGEMoutsopoulosHMIgG4 syndrome: old disease, new perspectiveJ Rheumatol20103771369137020595288
  • HamanoHKawaSHorinchAHigh serum IgG4 concentrations in patients with sclerosing pancreatitisN Engl J Med20013441073273811236777
  • CarruthersMNKhosroshahiAAugustinTDeshpandeVStoneJHThe diagnostic utility of serum IgG4 concentrations in IgG4-related diseaseAnn Rheum Dis2015741141824651618
  • AparisiLFarreAGomez-CambroneroLAntibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitisGut200554570370915831920
  • WillermainFJanssensSArsenijevicTOsmotic stress decreases aquaporin-4 expression in human epithelial cell line, ARPE-19Int J Mol Med201434253353824888368